LANTHEUS HOLDINGS INC (LNTH) Stock Price, Quote, News and Overview
NASDAQ:LNTH - Nasdaq - US5165441032 - Common Stock - Currency: USD
LNTH Quote, Performance and Key Statistics
NASDAQ:LNTH (6/30/2025, 1:18:27 PM)
82.19
+0.7 (+0.86%)
The current stock price of LNTH is 82.19 USD. In the past month the price increased by 7.91%. In the past year, price increased by 1.49%.
LNTH Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ALC | ALCON INC | 29.37 | 44.02B | ||
| COO | COOPER COS INC/THE | 18.25 | 14.16B | ||
| ALGN | ALIGN TECHNOLOGY INC | 20.24 | 13.68B | ||
| SOLV | SOLVENTUM CORP | 12.69 | 13.07B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 26.24 | 5.54B | ||
| BLCO | BAUSCH + LOMB CORP | 27.17 | 4.61B | ||
| HAE | HAEMONETICS CORP/MASS | 16.32 | 3.58B | ||
| ICUI | ICU MEDICAL INC | 18.68 | 3.21B | ||
| XRAY | DENTSPLY SIRONA INC | 9.45 | 3.16B | ||
| UFPT | UFP TECHNOLOGIES INC | 29.7 | 1.87B | ||
| ESTA | ESTABLISHMENT LABS HOLDINGS | N/A | 1.23B | ||
| NEOG | NEOGEN CORP | 12.82 | 1.06B |
Related stock screener links
About LNTH
Company Profile
Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The company is headquartered in North Billerica, Massachusetts and currently employs 808 full-time employees. The company went IPO on 2015-06-25. The company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Radiopharmaceutical Oncology diagnostics and therapeutics help healthcare professionals (HCPs) find, fight and follow cancer, with a focus on prostate cancer. Precision Diagnostic products assist HCPs to find and follow diseases, with a focus on cardiology. Strategic Partnerships focus on enabling precision medicine through the use of biomarker solutions, digital solutions, and radiotherapeutic platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, and others. Its clinical candidates include LNTH-2404, NAV-4694, and PNT2002, others. Its OCTEVY is a registrational-stage positron emission tomography (PET) diagnostic imaging agent targeting neuroendocrine tumors.
Company Info
LANTHEUS HOLDINGS INC
331 Treble Cove Rd
North Billerica MASSACHUSETTS 01862 US
CEO: Mary Anne Heino
Employees: 808
Phone: 19786718001
LANTHEUS HOLDINGS INC / LNTH FAQ
What is the stock price of LANTHEUS HOLDINGS INC today?
The current stock price of LNTH is 82.19 USD. The price increased by 0.86% in the last trading session.
What is the ticker symbol for LANTHEUS HOLDINGS INC stock?
The exchange symbol of LANTHEUS HOLDINGS INC is LNTH and it is listed on the Nasdaq exchange.
On which exchange is LNTH stock listed?
LNTH stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for LANTHEUS HOLDINGS INC stock?
19 analysts have analysed LNTH and the average price target is 131.89 USD. This implies a price increase of 60.47% is expected in the next year compared to the current price of 82.19. Check the LANTHEUS HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is LANTHEUS HOLDINGS INC worth?
LANTHEUS HOLDINGS INC (LNTH) has a market capitalization of 5.69B USD. This makes LNTH a Mid Cap stock.
How many employees does LANTHEUS HOLDINGS INC have?
LANTHEUS HOLDINGS INC (LNTH) currently has 808 employees.
What are the support and resistance levels for LANTHEUS HOLDINGS INC (LNTH) stock?
LANTHEUS HOLDINGS INC (LNTH) has a support level at 79.93 and a resistance level at 83.22. Check the full technical report for a detailed analysis of LNTH support and resistance levels.
Is LANTHEUS HOLDINGS INC (LNTH) expected to grow?
The Revenue of LANTHEUS HOLDINGS INC (LNTH) is expected to grow by 3.55% in the next year. Check the estimates tab for more information on the LNTH EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy LANTHEUS HOLDINGS INC (LNTH) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of LNTH, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of LNTH, evaluating the profitability, health, valuation and growth aspects
- LANTHEUS HOLDINGS INC (LNTH) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- LANTHEUS HOLDINGS INC (LNTH) Sales and EPS estimates to see what analysts future expectations are.
- LANTHEUS HOLDINGS INC (LNTH) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- LANTHEUS HOLDINGS INC (LNTH) Insider and Institutional Ownership to learn about the owners and their transactions.
- LANTHEUS HOLDINGS INC (LNTH) Stock Chart to make your own analysis
- LANTHEUS HOLDINGS INC (LNTH) Latest news and press-releases to stay up to date.
Does LANTHEUS HOLDINGS INC (LNTH) stock pay dividends?
LNTH does not pay a dividend.
When does LANTHEUS HOLDINGS INC (LNTH) report earnings?
LANTHEUS HOLDINGS INC (LNTH) will report earnings on 2025-07-29, before the market open.
What is the Price/Earnings (PE) ratio of LANTHEUS HOLDINGS INC (LNTH)?
The PE ratio for LANTHEUS HOLDINGS INC (LNTH) is 12.42. This is based on the reported non-GAAP earnings per share of 6.62 and the current share price of 82.19 USD. Check the full fundamental report for a full analysis of the valuation metrics for LNTH.
What is the Short Interest ratio of LANTHEUS HOLDINGS INC (LNTH) stock?
The outstanding short interest for LANTHEUS HOLDINGS INC (LNTH) is 11.83% of its float. Check the ownership tab for more information on the LNTH short interest.
LNTH Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to LNTH. When comparing the yearly performance of all stocks, LNTH is a bad performer in the overall market: 76.51% of all stocks are doing better.
LNTH Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to LNTH. LNTH has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
LNTH Financial Highlights
Over the last trailing twelve months LNTH reported a non-GAAP Earnings per Share(EPS) of 6.62. The EPS increased by 2.64% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 16.55% | ||
| ROA | 12.37% | ||
| ROE | 21.85% | ||
| Debt/Equity | 0.49 |
LNTH Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 82% to LNTH. The Buy consensus is the average rating of analysts ratings from 19 analysts.
For the next year, analysts expect an EPS growth of 0.57% and a revenue growth 3.55% for LNTH